JNJ-26366821 (TPOm) is a novel TPO mimetic that, like the approved TPO mimetics, has no sequence homology to endogenous TPO, mitigating the risk for generation of autoantibodies to endogenous TPO and subsequent thrombocytopenia. The gene discussed is TPO; the disease is Thrombocytopenia.